Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Wing beating tremors in Wilson's disease: An important clinical clue. | J Neurosci Rural Pract | 2023 | 37692815 | PubTator, text mining | PubMed |
| Novel mutations in ATP7B in Chinese patients with Wilson's disease and identification of kidney disorder of thinning of the glomerular basement membrane. | Front Neurol | 2023 | 37681011 | PubTator, text mining | PubMed |
| Paving the way for future gene therapies: A case study of scientific spillover from delandistrogene moxeparvovec. | Mol Ther Methods Clin Dev | 2023 | 37674905 | PubTator, text mining | PubMed |
| Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma. | Aging (Albany NY) | 2023 | 37665670 | PubTator, text mining | PubMed |
| Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives. | Mol Ther Oncolytics | 2023 | 37663132 | PubTator, text mining | PubMed |
| Commentary: Identification of cuproptosis hub genes contributing to the immune microenvironment in ulcerative colitis using bioinformatic analysis and experimental verification. | Front Immunol | 2023 | 37662945 | PubTator, text mining | PubMed |
| Metallothionein: a game changer in histopathological diagnosis of Wilson disease. | Histopathology | 2023 | 37661783 | PubTator, text mining | PubMed |
| Wilson disease-causing mutations in the carboxyl terminus of ATP7B regulates its localization and Golgi exit selectively in the unpolarized cells. | Metallomics | 2023 | 37660282 | PubTator, text mining | PubMed |
| A weighted cranial diffusion-weighted imaging scale for Wilson's disease. | Front Neurosci | 2023 | 37650098 | PubTator, text mining | PubMed |
| A Challenging Case of Wilson's Disease. | Cureus | 2023 | 37644923 | PubTator, text mining | PubMed |
| Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases. | Front Pharmacol | 2023 | 37637426 | PubTator, text mining | PubMed |
| Magnetic resonance imaging pontine signal abnormality in neurological Wilson disease: A case report. | Clin Case Rep | 2023 | 37636888 | PubTator, text mining | PubMed |
| Severe early-onset Wilson disease caused by a common pathogenic variant in the Bukharan Jewish population in Israel. | Gene | 2023 | 37634880 | PubTator, text mining | PubMed |
| Four-fold increased mortality rate in patients with Wilson's disease: A population-based cohort study of 151 patients. | United European Gastroenterol J | 2023 | 37632157 | PubTator, text mining | PubMed |
| Decoding Neurodegeneration: A Comprehensive Review of Molecular Mechanisms, Genetic Influences, and Therapeutic Innovations. | Int J Mol Sci | 2023 | 37629187 | PubTator, text mining | PubMed |
| OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC. | Int J Mol Sci | 2023 | 37629087 | PubTator, text mining | PubMed |
| Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma. | Biology (Basel) | 2023 | 37626987 | PubTator, text mining | PubMed |
| Human Exome Sequencing and Prospects for Predictive Medicine: Analysis of International Data and Own Experience. | J Pers Med | 2023 | 37623486 | PubTator, text mining | PubMed |
| Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis. | Aging (Albany NY) | 2023 | 37616061 | PubTator, text mining | PubMed |
| Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1. | Front Med (Lausanne) | 2023 | 37614950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=26